Silk Road Medical Inc Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Silk Road Medical Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • Silk Road Medical Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$16.6M, a 23.1% decline year-over-year.
  • Silk Road Medical Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$56.5M, a 6.92% decline year-over-year.
  • Silk Road Medical Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$55.7M, a 1.33% decline from 2022.
  • Silk Road Medical Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$55M, a 10.4% decline from 2021.
  • Silk Road Medical Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$49.8M, a 5.16% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$56.5M -$16.6M -$3.12M -23.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$53.4M -$14.1M +$2.32M +14.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$55.7M -$13M -$397K -3.15% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$55.3M -$12.8M -$2.47M -23.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$52.9M -$13.5M +$1.91M +12.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$54.8M -$16.5M +$219K +1.31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$55M -$12.6M +$2.08M +14.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$57.1M -$10.3M +$3.57M +25.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$60.7M -$15.4M -$4.86M -46.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$55.8M -$16.7M -$5.99M -56% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$49.8M -$14.7M +$2.06M +12.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$51.9M -$13.9M -$3.57M -34.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$48.3M -$10.5M -$186K -1.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$48.1M -$10.7M -$753K -7.58% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$47.4M -$16.8M -$8.47M -102% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$38.9M -$10.3M -$2.31M -28.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$36.6M -$10.4M +$1.61M +13.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$38.2M -$9.94M +$14.2M +58.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$52.4M -$8.29M +$7.33M +46.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$59.7M -$8.01M +$945K +10.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$60.7M -$12M -$4.31M -56.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$56.4M -$24.2M -$18.8M -347% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$37.6M -$15.6M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$8.95M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$7.65M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$5.41M Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.